Folliglan-F HP 75 IU Injection 1's

Folliglan-F HP 75 IU Injection 1's belongs to the class of drugs called hormones used in the treatment of female infertility in women whose ovaries do not produce eggs and in women receiving treatments like IVF (in-vitro fertilization). Infertility is unable to become pregnant after trying for a year. Female infertility may be caused due to different factors affecting ovulation (release of an egg from the ovary), fertilization (fusion of sperm and egg) and implantation (fertilized egg attaches to uterus lining).

Folliglan-F HP 75 IU Injection 1's contains Urofollitropin which works similarly to follicle-stimulating hormone (natural sex hormone). Folliglan-F HP 75 IU Injection 1's increases oestrogen production that stimulates the development of the egg and mature follicle in women having ovulation (release of an egg from the ovary) problems and those undergoing IVF treatments.

Take Folliglan-F HP 75 IU Injection 1's as prescribed by your doctor. You are advised to take Folliglan-F HP 75 IU Injection 1's for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience headache, stomach pain, nausea, vomiting, pelvic pain, hot flushes (sudden feeling of warmth) or inflammation of the throat and nasal passage. Most of these side effects of Folliglan-F HP 75 IU Injection 1's do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Folliglan-F HP 75 IU Injection 1's or any other medicines, please tell your doctor. Avoid taking Folliglan-F HP 75 IU Injection 1's if you are pregnant or breastfeeding and consult a doctor before taking Folliglan-F HP 75 IU Injection 1's. Avoid taking Folliglan-F HP 75 IU Injection 1's if you have tumours of the pituitary gland, hypothalamus, uterus, breasts or ovaries, vaginal bleeding, uterus fibroids, early menopause, malformations of sexual organs, cysts on ovaries or enlarged ovaries. If you experience weight gain, stomach pain, diarrhoea, nausea, vomiting, difficulty in breathing, decreased urination or swelling in the stomach after a few days of taking Folliglan-F HP 75 IU Injection 1's last dose, please consult a doctor immediately as these might be signs of high levels of activity in the ovaries.

Folliglan-F HP 75 IU Injection 1's contains Urofollitropin which works similarly to follicle-stimulating hormone (natural sex hormone). Folliglan-F HP 75 IU Injection 1's increases estrogen production that stimulates the development of the egg and mature follicle in women having ovulation (release of an egg from the ovary) problems and those undergoing IVF treatments.

• Headache
• Stomach pain
• Nausea
• Vomiting
• Pelvic pain
• Hot flushes (sudden feeling of warmth)
• Inflammation of throat and nasal passage

If you are allergic to Folliglan-F HP 75 IU Injection 1's or any other medicines, please tell your doctor. If you have hyperprolactinemia (high levels of prolactin hormone), tumours of the pituitary gland, hypothalamus, uterus, breasts or ovaries, underactive adrenal or thyroid glands, blood clots, vaginal bleeding, uterus fibroids, early menopause, malformations of sexual organs, cysts on ovaries or enlarged ovaries, inform your doctor before taking Folliglan-F HP 75 IU Injection 1's. Avoid taking Folliglan-F HP 75 IU Injection 1's if you are pregnant or breastfeeding and consult a doctor before taking Folliglan-F HP 75 IU Injection 1's. If you experience weight gain, stomach pain, diarrhoea, nausea, vomiting, difficulty in breathing, decreased urination or swelling in the stomach after few days of taking Folliglan-F HP 75 IU Injection 1's last dose, please consult a doctor immediately as these might be signs of high levels of activity in the ovaries.

Drug-Drug Interaction: Folliglan-F HP 75 IU Injection 1's may interact with ovary stimulants (clomiphene citrate) and drugs used to prevent premature ovulation (ganirelix).

Drug-Food Interaction: No interactions found.

Drug-Disease Interaction: If you have hyperprolactinemia (high levels of prolactin hormone), tumors of the pituitary gland, hypothalamus, uterus, breasts or ovaries, underactive adrenal or thyroid glands, vaginal bleeding, uterus fibroids, blood clots, early menopause, malformations of sexual organs, cysts on ovaries or enlarged ovaries, inform your doctor before taking Folliglan-F HP 75 IU Injection 1's.

• CLOMIPHENE
• GANIRELIX

• Avoid fried and processed foods.
• Take high-fat dairy such as whole milk instead of low-fat products.
• Include fibre-rich foods like whole grains, fruits and vegetables in your diet.
• Avoid refined carbohydrates that are high in sugars.
• Replace animal proteins (like eggs, fish and meat) with vegetable protein sources (nuts, seeds and beans).
• Avoid drinking excess alcohol or caffeinated drinks as they can worsen the symptoms.
• Maintain a healthy weight, do moderate exercise regularly.
• Avoid smoking and alcohol intake.

Blood tests and ultrasound scans are recommended to monitor your response to Folliglan-F HP 75 IU Injection 1's treatment.

Female infertility: Infertility is unable to become pregnant after trying for a year. Female infertility may be caused due to different factors affecting ovulation (release of an egg from the ovary), fertilization (fusion of sperm and egg), and implantation (fertilized egg attaches to uterus lining). The risk factors for infertility in females include smoking, heavy alcohol consumption, obesity, being underweight, increasing age, or having sexually transmitted infections. Also, certain medical conditions such as uterine fibroids, endometriosis, premature ovarian failure, polycystic ovary syndrome (PCOS), hormonal imbalances, scarring from previous surgery, or pelvic inflammatory disease may cause infertility in females.